[TAFRO syndrome and cutaneous necrotizing vasculitis].

La Revue de médecine interne
J MaquetL Sailler

Abstract

TAFRO syndrome is a systemic inflammatory syndrome in the spectrum of Castleman's disease, associating thrombocytopenia, anasarca, fever, renal failure and/or reticulin myelofibrosis and organomegaly. Its association with necrotizing cutaneous vasculitis has not yet been reported. A 69-year-old woman presented with weight loss, fever, anasarca, organomegaly, lymphadenopathy, anuria and extensive necrotic livedo occurring after acute diarrhea. Biology showed anemia, thrombocytopenia, renal failure, hypergammaglobulinemia, a circulating B-lymphocyte clone, hypoparathyroidism and autoimmune hypothyroidism. The skin biopsy showed small vessel vasculitis with fibrinoid necrosis. Methylprednisolone infusions associated with tocilizumab were ineffective and the patient became anuric. Rituximab and plasma exchanges associated to corticosteroids allowed remission for 2 months. Combination of rituximab, cyclophosphamide and dexamethasone resulted in a prolonged remission. We report here the first case of severe cutaneous necrotizing vasculitis in a patient suffering from TAFRO syndrome. The possible resistance to tocilizumab should be known.

References

May 24, 2008·International Journal of Surgical Pathology·Masaru KojimaShigeo Nakamura
May 27, 2010·Molecular Cancer Therapeutics·Hazem El-OstaRazelle Kurzrock
Apr 2, 2015·The American Journal of Medicine·Martin MichaudLaurent Sailler
Jan 20, 2016·Internal Medicine·Yusuke YamagaTakeshige Kunieda
May 18, 2016·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Sumie HiramatsuTsuneyo Mimori
Jun 2, 2016·International Journal of Hematology·Shunichiro YasudaTetsuya Fukuda
Oct 14, 2016·American Journal of Clinical Dermatology·Ayman Grada, Vincent Falanga
Feb 17, 2017·Scientific Reports·Noriko IwakiYasuharu Sato
Feb 7, 2018·Journal of Blood Medicine·Kentaro SakashitaMikio Takamori
Jul 1, 2018·Critical Reviews in Oncology/hematology·Semra Paydas
Jul 17, 2018·Clinical Nephrology. Case Studies·Yuhei NodaTomohiko Naruse
Aug 4, 2018·Nature Reviews. Disease Primers·Dario RoccatelloClodoveo Ferri
Jun 11, 2019·Internal Medicine·Satoko OkaMasaharu Nohgawa
Jun 22, 2019·American Journal of Hematology·Shino FujimotoYasufumi Masaki
Nov 12, 2019·Journal of Clinical and Experimental Hematopathology : JCEH·Yasufumi MasakiSadao Aoki
Nov 30, 2019·International Journal of Hematology·Yasufumi MasakiUNKNOWN Japanese TAFRO Syndrome Research Team
Feb 14, 2020·Oncogene·Akihide YoshimiWenbin Xiao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.